Ocular tissue levels of 1.5 percent levofloxacin ophthalmic solution compared to an active comparator [moxifloxacin]

Trial Profile

Ocular tissue levels of 1.5 percent levofloxacin ophthalmic solution compared to an active comparator [moxifloxacin]

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Feb 2009

At a glance

  • Drugs Levofloxacin; Levofloxacin; Moxifloxacin
  • Indications Bacterial infections; Ophthalmic infections
  • Focus Pharmacokinetics
  • Sponsors Santen Incorporated
  • Most Recent Events

    • 04 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top